Details for New Drug Application (NDA): 018877
✉ Email this page to a colleague
The generic ingredient in ALLOPURINOL is allopurinol sodium. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.
Summary for 018877
Tradename: | ALLOPURINOL |
Applicant: | Watson Labs |
Ingredient: | allopurinol |
Patents: | 0 |
Pharmacology for NDA: 018877
Mechanism of Action | Xanthine Oxidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 018877
Suppliers and Packaging for NDA: 018877
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALLOPURINOL | allopurinol | TABLET;ORAL | 018877 | NDA | Actavis Pharma, Inc. | 0591-5544 | 0591-5544-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5544-01) |
ALLOPURINOL | allopurinol | TABLET;ORAL | 018877 | NDA | Actavis Pharma, Inc. | 0591-5544 | 0591-5544-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5544-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
Approval Date: | Sep 28, 1984 | TE: | AB | RLD: | No |
Complete Access Available with Subscription